ATRECA INC's ticker is BCEL and the CUSIP is 04965G109. A total of 92 filers reported holding ATRECA INC in Q1 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $379 | -100.0% | 474 | -68.2% | 0.00% | – |
| Q3 2022 | $2,342,000 | -45.1% | 1,492 | -37.4% | 0.00% | – |
| Q2 2022 | $4,267,000 | -42.0% | 2,384 | +2.8% | 0.00% | – |
| Q1 2022 | $7,354,000 | -94.0% | 2,320 | -94.2% | 0.00% | – |
| Q4 2021 | $121,788,000 | +276.9% | 40,194 | +675.0% | 0.00% | – |
| Q3 2021 | $32,309,000 | +19.0% | 5,186 | +62.8% | 0.00% | – |
| Q2 2021 | $27,145,000 | -54.3% | 3,186 | -17.7% | 0.00% | – |
| Q1 2021 | $59,342,000 | -18.6% | 3,871 | -14.3% | 0.00% | – |
| Q4 2020 | $72,933,000 | -25.1% | 4,516 | -35.2% | 0.00% | – |
| Q3 2020 | $97,315,000 | +440.5% | 6,966 | +723.4% | 0.00% | – |
| Q2 2020 | $18,003,000 | -78.3% | 846 | -83.1% | 0.00% | – |
| Q1 2020 | $83,048,000 | +609.1% | 5,018 | +562.9% | 0.00% | – |
| Q4 2019 | $11,711,000 | +16.2% | 757 | -8.0% | 0.00% | – |
| Q3 2019 | $10,074,000 | – | 823 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,320,880 | $2,100,000 | 1.66% |
| CM Management, LLC | 249,282 | $391,000 | 0.44% |
| Aisling Capital Management LP | 387,653 | $609,000 | 0.40% |
| Boxer Capital, LLC | 2,202,333 | $3,458,000 | 0.19% |
| Samsara BioCapital, LLC | 396,835 | $623,000 | 0.14% |
| Redmile Group, LLC | 800,306 | $1,256,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 191,442 | $301,000 | 0.04% |
| Baker Brothers Advisors | 3,532,760 | $5,546,000 | 0.04% |
| Cormorant Asset Management, LP | 319,057 | $501,000 | 0.04% |
| Rock Springs Capital Management LP | 462,530 | $726,000 | 0.02% |